Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS

Solicitation Number: BAA-NIAID-DMID-NIHAI2013174
Agency: Department of Health and Human Services
Office: National Institutes of Health
Location: National Institute of Allergy and Infectious Diseases
  • Print

Note:

There have been modifications to this notice. To view the most recent modification/amendment, click here
:
BAA-NIAID-DMID-NIHAI2013174
:
Modification/Amendment
Please consult the list of document viewers if you cannot open a file.

Amendment 1

Type:
Mod/Amendment
Posted Date:
August 6, 2013
Description: Amendment 1
:
Office of Acquisitions
6700 B Rockledge Room 3214 MSC7612
Bethesda, Maryland 20892-7612
:
TBD

United States
:
Andrew Q Cherry,
Contract Specialist
Phone: 301-402-2443
Fax: 301-402-0972
:
Aileene Mitchell Ford,
Contracting Officer (Team Lead)
Phone: 301-496-7288
Fax: 301-402-0972